In Vivo Performance Articles & Analysis
5 news found
The abstract for the poster describes how Obsidian’s cytoTIL15 product (cytoTIL™ therapy engineered with mbIL15) demonstrates enhanced in vivo performance in the absence of IL-2, paving the way for more durable efficacy and improved safety in patients with solid tumor malignancies, and has been published in Molecular Therapy. Details of the poster: ...
Presentations on CTT1403 radiotherapeutic agent include: American Chemical Society meeting in San Francisco, April 2-6, 2017 “Improving the In Vitro and In Vivo Performance of a 177Lu-Labeled Phosphoramidate-Based PSMA Inhibitor with an Albumin-Binding Motif” Society of Nuclear Medicine and Medical Imaging meeting in Denver, June 10-14, 2017. ...
The static axial compressive loads that will be applied to the intervertebral body fusion devices and test blocks will differ from the complex loading seen in vivo, and therefore, the results from this test method may not be used to directly predict in vivo performance. ...
Additionally, those characteristics determined to be important to in vivo performance of the prosthesis are defined. The prostheses are classified into three kinds according to degree of constraint. ...
Scope 1.1 This specification provides a characterization of the design and mechanical function of external skeletal fixation devices (ESFDs), test methods for characterization of ESFD mechanical properties, and identifies needs for further development of test methods and performance criteria. The ultimate goal is to develop a specification, which ...